Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.09% dropped 0.09% to $179.46 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.36% rising 1.99% to 4,057.84 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.23% rising 1.61% to 32,637.19. This was the stock's second consecutive day of losses. Johnson & Johnson closed $7.23 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +0.77% rose 1.04% to $348.44, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.53% fell 1.54% to $92.31, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.15% rose 0.52% to $53.99. Trading volume (6.8 M) remained 778,499 below its 50-day average volume of 7.6 M.